A multicenter, multinational efficacy analysis was conducted from 2010 to 2012 to compare outcomes of patients with nonurinary esbl bsis who received a carbapenem 69 patients vs those treated with piperacillintazobactam 10 patients. Monographs for commonly administered intravenous medications in home and community care. Prospecto piperacilinatazobactam aurovitas 4 g0,5 g. Prospecto piperacilinatazobactam kabi 4 g0,5 g polvo. However, the majority of bsis originate from the urinary tract.
Carbapenems versus piperacillintazobactam for bloodstream. Prospecto piperacilinatazobactam sandoz 4 g0,5 g polvo. Tazobactam is a pharmaceutical drug that inhibits the action of bacterial. Zerbaxa, innceftolozane sulfate tazobactam sodium europa eu. Pdf pharmacokinetic evaluation of piperacillintazobactam. It is commonly used as its sodium salt, tazobactam sodium. Piperacilinatazobactam kabi prospecto piperacilina. Maxillofacial infections are a frequent cause for consulting maxillofacial surgeons. By continuing to browse this site you are agreeing to our use of cookies. Pharmacokinetic evaluation of piperacillintazobactam.
953 423 822 155 980 57 643 1217 715 1152 1120 246 898 1266 1289 1385 1216 1493 1322 840 658 396 20 5 977 465 134 1348 77 351 757 1487